Watchlist Price Alert

Marker Therapeutics Inc. (MRKR)

NASDAQ: MRKR · Real-Time Price · USD

1.16

-0.12 (-9.38%)

At close: May 09, 2025, 12:34 PM

Marker Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	19.19M	15.11M	11.78M	42.35M	21.35M	43.9M	61.75M	5.13M	7.85M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-17.8M	n/a	-21.2M	n/a	n/a	n/a	n/a
Receivables	2.35M	1.03M	2.4M	237.00	1M	56.19K	108.18K	n/a	n/a
Inventory	n/a	-988.13K	n/a	n/a	-1M	n/a	n/a	n/a	n/a
Other Current Assets	n/a	988.13K	585.84K	1.15M	n/a	1.53M	141.72K	n/a	n/a
Total Current Assets	22.02M	17.13M	16.62M	45.98M	24.41M	45.49M	62M	5.18M	7.92M
Property-Plant & Equipment	n/a	n/a	17.8M	22.15M	21.2M	873.17K	148K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	17.8M	22.15M	21.2M	873.17K	148K	n/a	n/a
Total Assets	22.02M	17.13M	34.42M	68.14M	45.61M	46.36M	62.14M	5.18M	7.92M
Account Payables	1.07M	961K	1.1M	5.14M	2.94M	993K	1.62M	1.01M	680K
Deferred Revenue	n/a	n/a	2.5M	1.15M	3.08M	765K	n/a	493K	544.76K
Short-Term Debt	n/a	n/a	n/a	620.49K	388.79K	204.13K	n/a	5K	5K
Other Current Liabilities	86.95K	1.84M	2.93M	3.32M	995.22K	149.55K	465.57K	166.31K	724.8K
Total Current Liabilities	3.46M	3.07M	7.78M	12.9M	6.4M	1.99M	2.8M	1.52M	1.74M
Long-Term Debt	n/a	n/a	n/a	11.25M	11.87M	280.25K	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	-11.25M	-11.87M	-280.25K	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	7.04M	11.25M	11.87M	280.25K	1.62M	1.02M	685.18K
Total Liabilities	3.46M	3.07M	14.82M	24.15M	18.27M	2.27M	2.8M	1.52M	1.74M
Total Debt	n/a	n/a	7.62M	11.87M	12.26M	484.38K	n/a	5K	5K
Common Stock	10.71K	8.89K	8.41K	83.08K	50.73K	45.73K	45.44K	10.62K	8.42K
Retained Earnings	-447,017.2B	-436.29M	-428.05M	-398.12M	-356.24M	-327.53M	-306.11M	-157.42M	-145.82M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	18,558.4B	14.05M	19.6M	43.99M	27.34M	44.09M	59.34M	3.66M	6.18M
Total Investments	19,192.4B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a